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Pmaging and Quantification of
yocardial Perfusion Using Real-Time
hree-Dimensional Echocardiography
ran Toledo, PHD,* Roberto M. Lang, MD,* Keith A. Collins, MS,* Georgeanne Lammertin, BS,*
rsula Williams, BS,† Lynn Weinert, BS,* Gil Bolotin, MD, PHD,† Patrick D. Coon, BS,*
ai Raman, MD, PHD,† Lawrence D. Jacobs, MD,* Victor Mor-Avi, PHD*
hicago, Illinois
OBJECTIVES We tested the feasibility of real-time three-dimensional echocardiographic (RT3DE)
perfusion imaging and developed and validated an algorithm for volumetric analysis of
myocardial contrast inflow. The study included three protocols wherein perfusion was
measured: 1) in an ex-vivo model of controlled global coronary flow, 2) in an in-vivo model
during regional perfusion variations, and 3) in humans during pharmacologically induced
hyperemia.
BACKGROUND The RT3DE technology offers an opportunity for myocardial perfusion imaging without
multi-slice reconstruction and repeated contrast maneuvers.
METHODS Electrocardiographically triggered harmonic RT3DE datasets were acquired (Philips 7500)
while infusion of Definity was initiated and reached a steady state. Protocol 1 was performed
in nine isolated rabbit hearts and included three coronary flow levels. In protocol 2, changes
in regional perfusion caused by partial left anterior descending artery occlusion were measured
in five pigs. In protocol 3, adenosine-induced changes in perfusion were measured in eight
normal volunteers. Myocardial video-intensity (MVI) was measured over time in three-
dimensional (3D) slices to calculate peak contrast inflow rate (PCIR). In pigs, PCIR was
measured on a regional basis and validated against microspheres.
RESULTS The RT3DE imaging allowed selection of slices for perfusion analysis in rabbit hearts, pigs,
and humans. Administration of contrast resulted in clearly visible and quantifiable changes in
MVI. In rabbits, The PCIR progressively decreased with coronary flow (p 0.0001). In pigs,
coronary occlusion caused a 59  26% decrease in PCIR exclusively in the left anterior
descending artery territory (p 0.05) in agreement with microspheres. In humans, adenosine
increased PCIR to 198  57% of baseline (p  0.05).
CONCLUSIONS Contrast-enhanced RT3DE imaging provides the basis for volumetric imaging and quanti-
fication of myocardial perfusion. (J Am Coll Cardiol 2006;47:146–54) © 2006 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.053American College of Cardiology Foundation
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oultiple studies have shown the feasibility of contrast-
nhanced, two-dimensional (2D) echocardiography for im-
ging myocardial perfusion (1). This methodology is limited
ecause the extent of a perfusion defect cannot be accurately
ssessed from a single slice of the heart. Until recently,
hree-dimensional (3D) imaging had been mainly based on
onsecutive acquisition of multiple planes followed by off-
ine volume reconstruction (2,3). Furthermore, quantifica-
ion of myocardial perfusion requires dynamic changes in
yocardial contrast, such as boluses of contrast media (4,5).
owever, the use of contrast boluses is confounded by the
eed to guess a priori the imaging settings for optimal
isualization of the short-lived enhancement. Microbubble
estruction with high-energy ultrasound pulses during con-
rast infusion (6–8) has been used as an alternative maneu-
er with 2D imaging. Volumetric assessment of perfusion
rom 3D reconstructed data would require these maneuvers
From the *Noninvasive Cardiac Imaging Laboratory and the †Section of Cardio-
horacic Surgery, University of Chicago, Chicago, Illinois. Supported by the Amer-
can Heart Grant-in-Aid and by a grant from Bristol-Myers Squibb.q
Manuscript received May 10, 2005; revised manuscript received August 4, 2005,
ccepted August 8, 2005.o be repeated for each imaging plane, which is impractical
or clinical use.
The recently developed real-time three-dimensional
chocardiographic (RT3DE) imaging technology offers an
pportunity for online volumetric perfusion imaging with-
ut the need for volume reconstruction and repeated con-
rast maneuvers. Previous investigators reported visualizing
erfusion defects as dark areas in contrast-enhanced
T3DE datasets (9). However, such use of reduced video-
ntensity as the sole indicator of a perfusion abnormality can
e hindered by drop-out artifacts that are commonly seen
ith contrast and are even more difficult to explain in 3D.
he optimal contrast maneuver for perfusion quantification
rom RT3DE datasets has yet to be determined. Although
oluses are likely to suffer the same known limitations in 3D
se, the alternative of using high-energy pulses is unresolved
ith RT3DE technology and may not become available
ecause of the excessive energy required for microbubble
estruction in the entire heart. Therefore, there is a need for
n alternative contrast maneuver that would allow time to
ptimize imaging settings and that could be safely used to
uantify perfusion from RT3DE images.
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January 3, 2006:146–54 3D Assessment of Myocardial PerfusionWe hypothesized that the current RT3DE technology
ould allow live volumetric perfusion imaging and that
uantification could be achieved by tracking changes in
yocardial contrast during the transition from no enhance-
ent to steady-state enhancement. The goals of this study
ere to: 1) develop and validate an algorithm for quantita-
ive volumetric assessment of myocardial perfusion based on
nalysis of transient contrast inflow (TCI); 2) test and
alidate this technique in vivo; and 3) test the applicability
f this technique to human data. Accordingly, this study
ncluded three protocols. The goal of protocol 1 was to
alidate perfusion measurements against direct flow mea-
urements during controlled changes in global coronary flow
n an isolated heart preparation. Protocol 2 was designed to
etect regional perfusion variations using transthoracic
T3DE imaging and provide validation against the micro-
phere gold standard in pigs undergoing partial coronary
cclusion. Protocol 3 was aimed at testing the applicability
f our approach in human subjects, which was achieved by
easuring pharmacologically induced changes in myocar-
ial perfusion in a group of normal subjects.
ETHODS
solated heart preparation. Experiments were performed
n nine male New Zealand White rabbits (2.2 to 2.8 kg).
nimals were pre-anesthetized (xylazine, 5 mg/kg; glyco-
yrrolate, 0.01 mg/kg intramuscularly), anesthetized (ke-
amine, 45 mg/kg; acepromazine, 1 mg/kg intramuscularly),
nd mechanically ventilated. After mid-sternotomy, the
eart was quickly removed and attached to a Langendorff
pparatus, and perfused in a retrograde fashion via the aortic
oot with Krebs-Henseleit solution, continuously gassed
ith carbogen at 38°C. Global coronary flow was controlled
sing a mechanical regulator and continuously monitored
sing an ultrasonic in-line flowmeter. Perfusion pressure
as kept constant at 86 mm Hg, and the heart was allowed
o beat spontaneously. Left atrial tissue was dissected, and a
atex balloon introduced into the left ventricular (LV) cavity
ia the mitral annulus and filled with fluid to allow physi-
logic pressures during isovolumic contractions. The LV
ressure was measured continuously using a catheter-tip
Abbreviations and Acronyms
2D  two-dimensional
3D  three-dimensional
BL  baseline
LAD  left anterior descending
LV  left ventricular
MVI  myocardial video-intensity
PCIR  peak contrast inflow rate
RT3DE  real-time three-dimensional
echocardiographic
TCI  transient contrast inflowransducer. The heart was immersed in Krebs-Henseleit colution at 38°C in a plastic container with thin (1 mm)
alls.
arge animal preparation. Experiments were performed
n five male farm pigs (20 to 28 kg). Animals were
re-treated with telazol (2.2 mg/kg, intramuscularly) and
tropine sulfate (0.05 mg/kg, intramuscularly). Indometha-
in (100 mg, per orogastric tube) was given to suppress
llergic reactions. After intubation, pigs were mechanically
entilated (Drager, Drager Medical, Lubeck, Germany) and
nesthetized with isoflurane (0.5% to 2.5% mixed with
xygen). Electrocardiogram, blood pressure, and expiratory
ases were monitored (Cardiocap, Datex, Madison, Wis-
onsin). Lidocaine was administered as a bolus (1 mg/kg,
ntravenously), and then infused (4 mg/kg/h) to prevent
rrhythmias. An intracoronary balloon catheter (2.0 to 2.5
m in diameter) was positioned under fluoroscopic guid-
nce near the origin of the left anterior descending (LAD)
rtery to maximize the affected perfusion territory. To
nsure partial occlusion, distal coronary flow was visually
ssessed by intracoronary Renografin injections during brief
alloon inflations, and balloon position adjusted if neces-
ary. A 7-F catheter was placed in the left atrium for
icrosphere injections.
uman subjects. Eight normal volunteers (age 31  6
ears) with high-quality transthoracic images were studied
n the left lateral decubitus position.
ltrasound imaging. The RT3DE imaging was per-
ormed using a SONOS 7500 system (Philips Medical
ystems, Andover, Massachusetts) equipped with a matrix-
rray transducer (X4) in the harmonic mode (1.6-MHz
ransmit frequency). The spatial aperture was set to be the
idest available (58°  29°) for triggered acquisition of
eries of end-systolic pyramidal datasets. Contrast enhance-
ent was achieved by infusion of Definity (Bristol-Myers
quibb, North Billerica, Massachusetts) (1.3 ml in 25 ml
aline). Infusion rate was determined by maximizing myo-
ardial contrast without visible attenuation. To minimize
ubble destruction, the minimal mechanical index necessary
o visualize myocardial contrast was used (0.4 to 0.8).
The isolated heart was imaged through the container
all, with the transducer stabilized using a flexible arm. The
yramidal volume of acquisition contained the entire heart
Fig. 1A). Contrast solution was infused at 16 to 25 ml/h
nto the perfusion line just proximal to the heart. In pigs,
maging was performed from the left parasternal approach,
esulting in volumetric short-axis datasets containing the
id portion of the left ventricle (Fig. 1B). Contrast solution
as infused intravenously (150 to 260 ml/h). In humans,
maging was performed from apical windows, resulting in
olumetric datasets containing mostly the lateral and septal
alls and parts of the inferior and posterior walls near the
ase, whereas the more distal parts of these walls were not
ncluded (Fig. 1C). Contrast solution was infused intrave-
ously (300 to 360 ml/h).
The TCI maneuver (Fig. 2) included: 1) optimization ofontrast infusion rate and imaging settings during steady-
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3D Assessment of Myocardial Perfusion January 3, 2006:146–54tate enhancement; 2) infusion interruption to allow con-
rast clearance, which was expedited by continuous 2D
maging at a high mechanical index; and 3) resumption of
ontrast infusion, resulting in contrast inflow. Image acqui-
ition started approximately five seconds before the resump-
ion of infusion to capture the entire transition from
on-contrast to reinstated steady-state enhancement.
rotocol 1. In rabbit hearts, TCI maneuvers were initially
erformed under baseline (BL) conditions, and then at two
evels of reduced coronary flow achieved by partially ob-
tructing the perfusion line: 50% of BL flow (F1; 40% to
0% acceptable), and 15% of BL (F2; 10% to 20% accept-
ble). To minimize ischemic damage, flow reduction was
imited to four minutes with at least five minutes of
eperfusion. To assess the reproducibility of perfusion quan-
ification, three consecutive sequences were performed at
ach experimental phase.
rotocol 2. In pigs, TCI maneuvers were initially per-
ormed under control conditions followed by reduced LAD
rtery flow and then reperfusion. Flow restriction was
igure 1. Schematic representation of volumetric acquisition in the three
olume; (B) volumetric parasternal short-axis imaging of the pig heart that
maging of the human heart that allows acquisition of a partial left ventri
igure 2. Schematic representation of the transient contrast inflow se-
uence. The upper portion of the diagram shows the time line of imaging
teps that comprise the sequence. The bottom portion shows the timing of
nfusion interruption and resumption (arrows) and their effects on the
yocardial contrast with the level of enhancement shown schematically ins
he shaded band below the time axis. 2D  two-dimensional; MI 
echanical index.chieved by intracoronary balloon inflation immediately
efore image acquisition (Fig. 2) and lasted 4 min,
llowing ultrasound imaging and microsphere measure-
ents to be performed under stable conditions. The reper-
usion sequence was initiated immediately after balloon
eflation with image acquisition beginning one to two
inutes after reflow. The respirator was stopped during
mage acquisition (1 min).
In three animals, NuFlow fluorescent microspheres (In-
eractive Medical Technologies, Irvine, California) were
njected over 30 s, followed by a 30-s 10-ml saline flush.
eference blood was collected from the femoral artery at 5
l/min over 2 min starting 5 s before microsphere injection.
icrospheres with different emission spectra were used at
ach experimental phase.
At the end of experiment, a lethal dose of pentobarbital
odium (120 mg/kg, intravenously) was given. In the three
nimals injected with microspheres, the heart was excised
nd the LV myocardium was cut into 1-cm-thick horizontal
lices. The slice containing the mid-ventricular portion was
ivided into six wedge-shaped segments and sent to a
pecialized laboratory for flow-cytometry analysis of tissue
lood flow.
rotocol 3. In human subjects, a TCI maneuver was
nitially performed at rest, followed by a repeated sequence
uring infusion of adenosine (0.142 ml/kg/min). In the
tress TCI sequence, adenosine infusion was initiated
hortly after infusion interruption. A set of images was
cquired two minutes later (Fig. 2). Image acquisition was
erformed during breath-hold. The total dose of Definity
as limited to a single 1.3-ml vial.
mage analysis. Images were analyzed using custom soft-
are. Initially, each pyramidal dataset was reviewed to allow
ocols: (A) isolated rabbit heart that fits entirely into the pyramidal scan
s acquisition of the mid portion of the left ventricle; (C) volumetric apical
volume that includes mostly the septal and lateral walls.protelection of parallel, 3.3-mm-thick slices. In rabbits, three
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January 3, 2006:146–54 3D Assessment of Myocardial Perfusionhort-axis slices were selected, including one slice at the
id-papillary level and two slices 5 mm above and below
Fig. 3, top). In pigs, two adjacent short-axis slices contain-
ng proximal and distal portions of the papillary muscles
ere selected. In both animal models, a roughly ring-
haped, 3.3-mm-thick region of interest (ROI) that in-
luded most of the LV myocardium was manually drawn in
ach slice. In pigs, the ROI was subdivided into six
edge-shaped segments. In humans, three adjacent apical
our-chamber slices were selected, including a mid-
entricular slice that contained the LV apex and two slices
hifted toward the anterior wall. For each slice, a 3D
orseshoe-shaped ROI was defined and its position was
djusted frame-by-frame, when necessary, to compensate
or translation.
In each ROI, mean myocardial video-intensity (MVI)
as calculated by averaging pixel intensity in each consec-
tive frame throughout the sequence to generate MVI over
ime curves. We assumed that myocardial contrast inflow
ollowed the indicator dilution equation:
MVI(t)  A [1  et]  C, where C is the initial MVI
efore contrast inflow, A is the maximum contrast-induced
ncrease in MVI, and  is the characteristic constant related
o tissue blood flow. The rate of change in MVI(t),
xpressed by its time derivative, would attain its peak value
A · ) at the onset of contrast inflow (at t  0). Thus, the
lope of MVI(t) near the onset of contrast inflow divided by
would represent . Accordingly, linear regression slope of
VI(t) was calculated from the first 11 time points (based
n preliminary experiments), starting where an increase
bove signal noise was detected. This slope was then
ormalized by the measured maximum contrast-induced
igure 3. Three-dimensional rendering of the isolated rabbit heart showing
evel, a roughly ring-shaped region of interest (ROI) was defined (top, righ
he effects of contrast enhancement (CE) on the different slices are showncrease in MVI (i.e., A), resulting in peak contrast inflow Iate (PCIR, in units of 1/s). To compensate for recirculation
nd possible differences in transpulmonary contrast passage
ates, myocardial PCIR values in protocols 2 and 3 were
ormalized by PCIRmeasured in the LV cavity and used as an
ndex of myocardial perfusion (unitless after normalization).
tatistical analysis. To assess the effects of coronary flow
estrictions in protocols 1 and 2, PCIR values obtained from
epeated measurements at each experimental phase were
ompared using analysis of variance with repeated measures.
or significant F-ratios, a Bonferroni post-hoc test was used
o specify pair-wise differences. The reproducibility of
CIR was assessed by calculating the inter-measurement
ariability, defined as the standard deviation of repeated
easurements in percent of their mean, for each animal, at
ach experimental phase. Inter-slice variability was defined
s the standard deviation of PCIR measured over different
lices selected from the same dataset in percent of their
ean. In protocol 3, baseline and adenosine-stress PCIR
alues were compared using paired t test. All p values 
.05 were considered significant.
ESULTS
solated heart experiments. At baseline, global coronary
ow was 43  8 ml/min and peak systolic LV pressure was
7  11 mm Hg. A decrease in coronary flow to 50% and
5% of baseline resulted in reduced peak systolic pressures
f 51  10 mm Hg and 26  10 mm Hg, respectively.
The RT3DE imaging allowed high-quality volumetric
endering of the entire heart (Fig. 3, top). Administration of
ontrast resulted in clearly visible and uniform dynamic
hanges in MVI in all LV slices (Fig. 3, middle vs. bottom).
each dataset was sliced at different levels of the left ventricle (top). At each
llow video-intensity measurements in three 3.3-mm-thick slices (middle).
the bottom panels.hown all rabbits, contrast inflow reached steady-state enhance-
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3D Assessment of Myocardial Perfusion January 3, 2006:146–54ent within 15 to 25 cardiac cycles at baseline and was
onger at lower coronary flows. Flow reduction resulted in a
lower intensity increase and eventually lower levels of
teady-state enhancement (Fig. 4, left). The PCIR followed
he changes in coronary flow at both levels of reduced flow,
1 and F2 (p  0.0001, Bonferroni-adjusted for two
omparisons; Fig. 4, right). Inter-slice variability was 9 
% and 9  4% for BL and F1, respectively, but was higher
or F2 (29  23%, p  0.05 vs. both BL and F1).
nter-measurement variability was 18  15% and was
imilar at all flow levels.
ig experiments. Baseline systolic and diastolic blood pres-
ures were 123  12 mm Hg and 60  10 mm Hg,
espectively, with no significant changes during partial
oronary occlusion. Heart rates ranged from 95 to 125
eats/min between animals, with no ischemia-related
hanges or wall-motion abnormalities. In all animals, visible
yocardial contrast clearance occurred within 90 s.
Figure 5 shows an example of a dataset that contains the
id portion of the left ventricle and en-face short-axis views
f a mid-papillary 3D slice obtained at different phases of
he TCI sequences at baseline and during LAD artery
cclusion. Although no differences were visible between the
re-contrast images (left), the LAD artery territory ap-
eared darker during steady-state enhancement, and con-
rast inflow was slower during restricted coronary flow
ompared with baseline (right). Regional MVI curves ob-
ained in the LAD artery territory during occlusion showed
slower rate of inflow to a lower steady-state level,
ompared with baseline (top right). Curves obtained in
egments outside the LAD artery territory were not affected.
Figure 6 shows the summary of regional perfusion mea-
ured in two myocardial slices in five pigs at baseline, during
artial coronary occlusion, and during reperfusion. Coro-
ary occlusion resulted in a significant decrease in PCIR in
he anterior and anteroseptal segments (56 29% and 62
6% decrease, respectively; p  0.05, Bonferroni-adjusted
or two comparisons) in both slices, with no concomitant
ecrease in other segments. These changes were reversed
ith reperfusion, during which PCIR values were not
igure 4. (Left) Example of myocardial video-intensity (MVI) time curve
evels of coronary flow: BL, baseline; F1, 40% to 60% of baseline flow; F2, 1
nflow rate (PCIR) measured at the different levels of coronary flow (*p ifferent from baseline. Microsphere measurements per- mormed during coronary occlusion averaged 43  12% of
aseline values in the anterior and anteroseptal segments,
ompared with 84  35% in the rest of the myocardium.
he inter-slice variability in regional PCIR at baseline was
2  18%.
uman studies. In all subjects, dynamic changes in MVI
ere visible and quantifiable in all slices, and visible contrast
learance occurred within 90 s. The transition from no
nhancement to steady-state enhancement occurred in all
ubjects within 45 s, and was captured in a single
cquisition. Figure 7 (top) shows an example of pyramidal
atasets that show an apical four-chamber view at different
hases of a resting TCI sequence. Figure 7 (bottom left)
hows MVI curves obtained at rest and during adenosine
nfusion. Adenosine resulted in increased contrast inflow
ate in all three myocardial slices in all subjects. Conse-
uently, PCIR with adenosine was 198  57% of the
esting value (p  0.0001) when averaged over the three
lices (bottom right), and was similar in all slices. The
nter-slice variability was 10  4% with no significant
ifference between rest and adenosine.
ISCUSSION
he ability of 2D contrast echocardiography to image
yocardial perfusion has been shown in multiple publica-
ions (10,11). This technique has lately been improved by
table contrast agents suitable for intravenous administra-
ion (6,7,12) and contrast-targeted imaging technology
e.g., power modulation and pulse inversion) that provides
igher sensitivity for detecting intramyocardial contrast
7,13–15). These improvements have made myocardial
erfusion imaging feasible, and importantly, reproducible in
he majority of patients.
Nevertheless, the ability of conventional perfusion imag-
ng to accurately determine the extent of perfusion defects is
imited by its 2D nature, which mandates repeated multi-
lane acquisition. Despite the obvious appeal of 3D imaging
n this context, this methodology has not been possible until
ecently because it has relied on volume reconstruction from
ined from one three-dimensional slice of an isolated rabbit heart at three
20% of baseline flow. (Right) Average values of myocardial peak contrast
01 compared with baseline) at each of the three levels of the ventricle.s obta
0% toultiple planes, essentially precluding the possibility of
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January 3, 2006:146–54 3D Assessment of Myocardial Perfusionigure 5. (Top left) Dataset that contains the mid portion of the left ventricle, obtained using transthoracic imaging in a pig (anteroseptal region [asp]
f interest shown in yellow). Example of en-face short-axis views of a mid-papillary three-dimensional slice obtained at baseline (middle row) and during
artial left anterior descending artery occlusion (bottom row) before the onset of (left) and during (center) myocardial contrast inflow, and (right) after
einstatement of steady-state contrast enhancement. (Top right) Regional myocardial video-intensity (MVI) curves obtained in the mid-papillary
nteroseptal region of interest: baseline (green) and partial left anterior descending artery occlusion (red). PCIR  peak contrast inflow rate.igure 6. (Left) En-face view of a three-dimensional short-axis slice of a pig heart with the myocardial region of interest divided into six segments. (Right)
egional peak contrast inflow rate (PCIR) (unitless after normalization) calculated from transient contrast inflow (TCI) sequences at baseline, during partial
eft anterior descending (LAD) artery occlusion, and during reperfusion, averaged over all animals (*p  0.05 vs. baseline). Different bar colors correspond
o specific myocardial segments (left). The two bars of each color represent regions of interest in adjacent slices. Ant  anterior; Asp  anteroseptal; Inf
inferior; Lat  lateral; Pst  posterior; Sep  septal.
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3D Assessment of Myocardial Perfusion January 3, 2006:146–54uantification that would require repeating contrast maneu-
ers for each plane. This study was designed to test the
ypothesis that the current RT3DE technology can provide
onsecutive scans of the entire volume during a single
ontrast maneuver and thus allow live volumetric perfusion
maging and quantification.
This is the first study to show the feasibility of real-time,
igh-resolution, contrast-enhanced 3D perfusion imaging
sing widely available equipment. To quantify perfusion, we
sed transient contrast inflow as an alternative to high-
nergy ultrasound pulses, which are not applicable with
T3DE imaging. An important advantage of the TCI
aneuver over bolus injections is the ample time it provides
o optimize gain settings before image acquisition. To
valuate this approach, we developed software for volumet-
ic analysis of TCI sequences aimed at quantification of
lobal and regional myocardial perfusion in multiple 3D
lices and tested it under various conditions.
The isolated heart preparation proved to be a valuable
ool because it provided near-ideal conditions for contrast-
nhanced imaging (5). This protocol provided the scientific
asis for further evaluation in pigs and humans. Our results
n this experimental setup proved the feasibility of both
T3DE imaging and quantitative volumetric assessment of
yocardial perfusion. Our approach to the analysis of MVI
ime curves provided reproducible values of PCIR, which
irectly reflected the changes in coronary flow. Moreover,
he low inter-slice variability of PCIR indicates that this
igure 7. (Top) Near en-face apical four-chamber view of the left ventricle
equence (left to right). (Bottom left) Corresponding myocardial video-i
yocardial slice. (Bottom right) Summary of peak contrast inflow rate (pe
yocardial slices and averaged over all study subjects (*p  0.01 vs. baselarameter is a reliable index of myocardial perfusion. The tncrease in inter-slice variability between non-adjacent slices
uring 85% flow restriction is likely attributable to the
on-uniform flow distribution in severely underperfused
yocardium. Importantly, the inter-measurement vari-
bility was lower than the inter-slice variability, indicat-
ng that the former is unlikely to be related to a
easurement error, but rather represents physiologic
on-uniformity in perfusion.
Another noteworthy finding is that although PCIR
ollowed the changes in coronary flow, it was not propor-
ional to flow (50% flow reduction caused a smaller decrease
n PCIR). This could be explained by the fact that the
ontrast infusion rate was kept constant and was not
djusted for reduced coronary flow, resulting in higher
ontrast concentrations at lower flows. Although our tech-
ique includes normalization by contrast-induced change in
ideo-intensity, the non-linear relationship between video-
ntensity and bubble concentration may explain this finding.
Our pig experiments were designed to test this approach
n vivo using transthoracic imaging and to validate regional
olumetric perfusion measurements against microspheres.
he use of partial coronary occlusion in a closed-chest pig
rovided an experimental model of reduced coronary flow
ithout ischemia. This model was chosen to test this
echnique under conditions of a moderate decrease in
erfusion, which is more difficult to detect visually than the
ear-complete lack of perfusion caused by critical coronary
tenosis. The results of this protocol showed that our
ined in a normal volunteer at different phases of a transient contrast inflow
ity (MVI) curves obtained at rest and during adenosine infusion in one
ntrast inflow rate [PCIR], unitless after normalization) measured in threeobta
ntensechnique could be used to detect a moderate reduction in
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January 3, 2006:146–54 3D Assessment of Myocardial Perfusionyocardial perfusion, which was confirmed by micro-
pheres, on a regional basis. The relatively low baseline
nter-slice variability indicates that PCIR is a reliable
erfusion index even on a regional basis. Inter-slice variabil-
ty was not tested during occlusion because uniform distri-
ution of blood flow was not expected under these condi-
ions. In addition, our attempted solution for the issues of
ecirculation and differences in transpulmonary contrast
assage proved effective because it resulted in a relatively
mall standard deviation in PCIR (Fig. 6), reflecting the low
nter-animal variability of this index.
Protocol 3 was aimed at initial testing of clinical appli-
ability of RT3DE perfusion imaging with TCI as the
ontrast maneuver for quantification. This was achieved by
easuring pharmacologically induced changes in myocar-
ial perfusion in a small group of normal subjects. This
trategy was chosen because the clinical application of this
pproach is the detection of stress-induced perfusion abnor-
alities (Fig. 8). The use of normal subjects allowed us to
alidate our technique against the anticipated normal re-
ponse to adenosine, which is a marked increase in myocar-
ial perfusion in the absence of coronary artery disease. Our
esults indeed showed a two-fold increase in the measured
erfusion index. Although one might expect a larger in-
rease (three- to five-fold) in response to adenosine, the
on-linear relationship between contrast concentration and
ideo-intensity may explain this dampened response.
The results of this protocol also showed that contrast
learance and inflow occur within a time frame applicable in
he clinical setting. Importantly, the TCI maneuver does
ot require complete contrast clearance before resuming
nfusion, but instead relies on the temporal aspects of the
elative change in contrast levels during inflow. Of note, the
ow inter-slice variability in global PCIR essentially did not
ncrease in the transition from the isolated heart preparation
o humans. These results indicate that RT3DE perfusion
igure 8. Pyramidal dataset obtained in a patient with severe discrete left
hows clear lack of contrast enhancement, indicating a perfusion defect th
ross-sections (right), allowing easy estimation of its extent.uantification can be reliably performed in humans and ustablish the basis for future clinical studies geared toward
he validation of this technique in different cardiac disease
tates.
tudy limitations. Our measurements were not directly
alidated against microspheres in every experiment. This is
ecause PCIR is an index related to perfusion rather than an
bsolute perfusion measurement and therefore cannot be
irectly compared with microsphere data. In the isolated
eart experiments, changes in global myocardial perfusion
ere validated using direct measurements of coronary flow.
lso, no regional variations in myocardial perfusion were
nduced in this setup because of the known high prevalence
f collateral circulation in rabbits (16). In the pig experi-
ents, which were designed to study changes in regional
erfusion, the reduction in LAD artery flow was confirmed
y angiography in every animal. Microspheres were only
sed in a subset of animals to confirm the effectiveness of
oronary occlusion using a widely accepted gold standard
echnique.
The initial feasibility in humans was tested in normal
ubjects selected based on quality of images. The RT3DE
erfusion imaging needs to be evaluated in larger groups of
nselected patients, which will also allow determining the
mpact of suboptimal images such as those frequently
ncountered in clinical practice. Also, this study was per-
ormed using harmonic imaging rather than a contrast-
argeted mode, which might further improve the sensitivity
o intramyocardial contrast. Another limitation of the
T3DE technology is the limited spatial aperture angle,
hich does not allow imaging the entire ventricle. This
imitation mostly stems from insufficient computational
esources and does not represent a fundamental constraint
f this technology. Therefore, while anticipating a techno-
ogical solution to this issue, we focused on testing the
easibility of volumetric perfusion imaging and quantifica-
ion in a partial volume of the heart that can be scanned
ior descending artery stenosis (left). A part of the interventricular septum
s supported by abnormal wall motion. This defect was visible in multipleantersing the current RT3DE equipment.
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e found that RT3DE imaging and quantification of
yocardial perfusion within a single contrast maneuver is
easible, and that PCIR is a sensitive, accurate, and repro-
ucible index that can be used to track global and regional
hanges in myocardial perfusion. This approach can poten-
ially allow more accurate assessment of the extent of
erfusion defects than 2D myocardial contrast echocardiog-
aphy. The potential clinical use of this technique for the
iagnosis of ischemic heart disease may have important
mplications for the future of myocardial contrast echocar-
iography.
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